As the World Health Organization (WHO) issues its first global guideline on the use of GLP‑1‑based therapies for obesity in adults, attention is shifting from scientific possibility to a more difficult question: how these advances can reach the people who need them most. The guideline recognises obesity as a chronic disease and calls for equitable, […]
06 March 2026
Keyword